Chiasma Inc (NASDAQ:CHMA) submitted a marketing application to the European Medicines Agency seeking approval of Mycapssa (oral octreotide capsules) as maintenance…
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.
Gainers
Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.
Toward the end of trading Wednesday, the Dow traded up 0.53% to 34,313.88 while the NASDAQ rose 0.18% to 13,658.26. The S&P also rose, gaining 0.41% to 4,181.69.